VANCOUVER, BC and MESA, AZ, Jan. 9, 2014 /CNW/ - Avidus Management Group
Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF), announces
that its wholly owned subsidiary, Asantae, has published a White Paper
on IS2™, its revolutionary inflammation and immune support functional
beverage. The paper, by Dwight Lundell, M.D., is titled, The Science of Inflammation & Immunity.
IS2™ is a proprietary blend of unique ingredients synergistically combined
to support a proper immune and inflammatory response.
The White Paper details how 60 percent of the deaths worldwide today are
from non-communicable diseases (e.g. heart disease, stroke, obesity,
diabetes) and that the common pathology in all these diseases, as well
as in less dramatic conditions that plague humankind (e.g. chronic
pain, fibromyalgia, osteoarthritis), is inflammation. The document
also explores how the ingredients found in IS2™ are shown to aid in
resolving inflammation by strengthening the body's natural immune
system and inflammatory processes.
Launched in October 2013, IS2™ is generating positive feedback from
Asantae's customers and distributors and has enabled the company to
attract top network marketers from other well-established companies.
About Avidus
Avidus Management Group Inc. (TSX-V: AVD, OTC: ASNHF), through its
wholly owned subsidiary, Asantae (www.asantae.com), develops, produces and markets innovative nutritional products
through direct and network marketing channels. The ingredients in
Asantae's products have been shown to reduce chronic low-grade
inflammation and oxidative stress, and support a healthy immune system
that, according to scientific and medical research, are the underlying
conditions for most modern epidemic diseases (diabetes, heart disease,
obesity, stroke, etc.).
This news release may contain forward-looking statements relating to the
Company's operations or to the environment in which it operates. Such
statements are based on operations, estimates, forecasts and
projections. They are not guarantees of future performance and involve
risks and uncertainties that are difficult to predict and may be beyond
the Company's control. A number of important factors could cause actual
outcomes and results to differ materially from those expressed in
forward-looking statements, including those set forth in the Company's
regulatory filings. In addition, such statements relate to the date on
which they are made and the Company disclaims any intention or
obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise, save and
except as may be required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE Avidus Management Group Inc.
Avidus Management Group, Inc.
Doug Ridley, President
10153 E Hampton Ave, Ste 101, Mesa, AZ, 85209 USA
P: 480-278-8712 / F: 480-383-6147
Sequoia Partners Inc.
James Beesley, james@sequoiapartners.ca, P: 778-389-7715
Adam Rabiner, adamr@sequoiapartners.ca, P: 604-868-7881
Copyright CNW Group 2014